Prooxidant-antioxidant balance in stroke patients and 6-month prognosis

Clinical Laboratory

Volumn 57, Issue 3-4, 2011, Pages 183-191

  Parizadeh, Mohammad Reza ^a   Azarpazhooh, Mahmoud Reza ^a   Mobarra, Naser ^b   Nematy, Mohsen ^a   Alamdari, Dariush Hamidi ^a   Tavalaie, Shima ^b   Sahebkar, Amirhossein ^b   Hassankhani, Bahareh ^b   Ferns, Gordon ^c   Ghayour Mobarhan, Majid ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE

Author keywords

Oxidative stress; Prooxidant antioxidant balance; Stroke

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; OXIDATIVE STRESS; PATIENT ASSESSMENT; PROGNOSIS; PROOXIDANT ANTIOXIDANT BALANCE; STROKE; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REACTIVE OXYGEN SPECIES; STROKE;

EID: 79956031319     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367: 1747-57.
2. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31: 1588-601.
3. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-63. (Pubitemid 29494766)
4. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005; 39:841-52.
5. Azarpazhooh MR, Mobarra N, Parizadeh SMR, et al. Serum High-Sensitivity C-Reactive Protein and Heat Shock Protein 27 Antibody Titers in Patients With Stroke and 6-Month Prognosis. Angiology, In Press,doi:10.1177/0003319709360524.
6. ElKossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000;31:1889-92.
7. Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C. Oxidative stress in acute ischemic stroke. J Clin Neurosci 2007;14:1062-6. (Pubitemid 47588935)
8. Aygul R, Kotan D, Demirbas F, Ulvi H, Deniz O. Plasma oxidants and antioxidants in acute ischemic stroke. J Int Res 2006; 34:413-8. (Pubitemid 44363577)
9. Yang TH, Chang CY, Hu ML. Various forms of homocysteine and oxidative status in the plasma of ischemic-stroke patients as compared to healthy controls. Clin Biochem 2004;37:494-9.
10. Bir LS, Demir S, Rota S, Köseoǧlu M. Increased serum malondialdehyde levels in chronic stage of ischemic stroke. Tohoku J Exp Med 2006;208:33-9.
11. Loh KP, Huang SH, De Silva R, Tan BK, Zhu YZ. Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res 2006;3: 327-37. (Pubitemid 44351476)
12. Faraji F, Ranjbar A, Eshrati B, Talaie A, Shafie N, Pirasteh SH. Comparing the oxidative stress indexes of CVA patients with control group. Rahavard Danesh, J Arak Univ Med Sci 2008;3: 109-16.
13. Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007;40:248-54.
14. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, et al. Prooxidant- antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008;41:375-80.
15. Azarpazhooh MR, Etemadi MM, Donnan GA, et al. Excessive incidence of stroke in Iran. Evidence from the Mashhad Stroke Incidence Study (MSIS): A Population-Based Study of Stroke in the Middle East. Stroke 2010;41:e3-e10.
16. Ghayour-Mobarhan M, Sahebkar A, Parizadeh SM, et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol 2008;89:209-15. (Pubitemid 351661567)
17. Re G, Azzimondi G, Lanzarini C, Bassein L, Vaona I, Guarnieri C. Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism. Eur J Emerg Med 1997;4:5-9.
18. Polidori MC, Frei B, Cherubini A, et al. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 1998;25:561-7. (Pubitemid 28390312)
19. Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 2003;74:312-6. (Pubitemid 36259353)
20. Belch J, McLaren M, Hanslip J, Hill A, Davidson D. The white blood cell and plasma fibrinogen in thrombotic stroke: a significant correlation. Int Angiol 1998;17:120-4. (Pubitemid 28524084)
21. Sharpe PC, Mulholland C, Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci. 1994;163:488-91. (Pubitemid 24343177)
22. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. Q J Med 2002;95:685-90. (Pubitemid 35203637)
23. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-40. (Pubitemid 120036914)
24. Esterbauer H. Estimation of peroxidative damage. A critical review. Pathol Biol (Paris) 1996;44:25-8.
25. Chang CY, Lai YC, Cheng TJ, Lau MT, Hu ML. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic Res 1998;28:15-24.
26. Lin SN, Homing EC. Concurrent determination of alpha-tocopherol and free fatty acids in human plasma by glass open tubular capillary column gas chromatography. J Chromatogr 1975;112: 465-82.
27. Hume R, Vallance BD, Muir MM. Ascorbate status and fibrinogen concentrations after cerebrovascular accident. J Clin Pathol 1982;35:195-9. (Pubitemid 12132502)
28. Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 1999;30: 2535-40.
29. Alexandrova M, Bochev P, Markova V, et al. Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J Clin Neurosci 2004;11:501-6. (Pubitemid 38869480)
30. Gruener N, Gross B, Gozlan O, Barak M. Increase in superoxide dismutase after cerebrovascular accident. Life Sci 1994;54:711-3.
31. De Keyser J, De Klippel N, Merkx H, Vervaeck M, Herroelen L. Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. Lancet 1992;339:1562-5.
32. Imre SG, Fekete I, Farkas T. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994;25:2416-20. (Pubitemid 24359312)
33. Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AGP. Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefe's Arch Clin Exp Ophthalmol 2008;246:1477-83.
34. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, et al. Prooxidant- antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2007;41:375-80.
35. Ghayour-Mobarhan M, Alamdari DH, Moohebati M, et al. Determination of prooxidant-antioxidant balance after acute coronary syndrome using a rapid assay: A pilot study. Angiology 2009;60:657-62.
36. Tara F, Rayman MP, Boskabadi H. Prooxidant-antioxidant balance in pregnancy: a randomized double-blind placebo-controlled trial of selenium supplementation. J Perinat Med, Epub ahead of print.
37. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res 2002;36:265-8. (Pubitemid 35154069)
38. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-6. (Pubitemid 36944787)
39. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002;33: 1048-52. (Pubitemid 34293590)
40. Spranger M, Krempien S, Schwab S, Donneberg S, Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 1997;28:2425-8.
41. Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000;31: 2295-300.
42. Reeder BJ, Wilson MT. Hemoglobin and myoglobin associated oxidative stress: From molecular mechanisms to disease states. Curr Med Chem 2005;12:2741-51. (Pubitemid 41601571)
43. Samouilidou E, Grapsa E, Karpouza A, Lagouranis A. Reactive oxygen metabolites: A link between oxidative stress and inflammation in patients on hemodialysis. Blood Purif 2007;25:175-8. (Pubitemid 46447076)
44. Cottone S, Palermo A, Vaccaro F, et al. In renal transplanted patients inflammation and oxidative stress are interrelated. Transplant Proc 2006;38:1026-30.
45. Priya R, Vasudha KC. Antioxidant vitamins in chronic renal failure. Biomed Res 2009;20:67-70.
46. Keaney Jr. JF, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003;23: 434-9. (Pubitemid 36337219)
47. Block G, Dietrich M, Norkus EP, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002; 156:274-85. (Pubitemid 34810481)
48. Ohmori K, Ebihara S, Kuriyama S, et al. The relationship between body mass index and a plasma lipid peroxidation biomarker in an older, healthy Asian community. Ann Epidemiol 2005;15:80-4. (Pubitemid 39574918)